J&J's propofol administration device finally wins FDA nod

Johnson & Johnson ($JNJ) won FDA approval for its Sedasys device to administer the sedative propofol, often used in colonoscopy patients, without the need for ongoing monitoring by an anesthesiologist. Release | Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.